Stay updated on AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial

Sign up to get notified when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page footer.
    Difference
    0.0%
    Check dated 2026-02-11T14:36:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 on the page. This appears to be a software/version update and does not alter study content.
    Difference
    0.0%
    Check dated 2026-02-04T10:52:19.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a glossary toggle to show glossary on the page. Minor label capitalization changes for QC-related text and a new revision tag (v3.4.0).
    Difference
    0.2%
    Check dated 2026-01-28T07:49:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Key study documentation and explanatory materials were removed from the page, including the lay summary, informed consent form, SAP, study protocol, IPD sharing information, and the Clinical Study Report. This reduces access to essential details about the study design, participant protections, and data-sharing terms.
    Difference
    21%
    Check dated 2026-01-21T05:48:34.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears on the page, replacing the previous v3.3.3. This looks like a site version update with no impact on the study details.
    Difference
    0.0%
    Check dated 2026-01-14T03:56:10.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Locations section added: Connecticut, Massachusetts, New York, and Tennessee; HHS Vulnerability Disclosure link removed.
    Difference
    0.4%
    Check dated 2025-12-23T20:38:41.000Z thumbnail image

Stay in the know with updates to AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.